Special series on RCC: Beyond first-line treatment strategies for mRCC with Dr. Mari and Dr. Ciccarese
In 'Episode 3', the final of the series on "Metastatic renal cell carcinoma", Dr. Andrea Mari (IT) talks with Dr. Chiara Ciccarese (IT) from the Medical Oncology Unit at Fondazione Policlinico Univers...
9 Maalis 202413min
Special series on RCC: First-line treatment strategies for mRCC with Dr. Mari and Dr. Marandino
In 'Episode 2' of the series on "Metastatic renal cell carcinoma", Dr. Andrea Mari (IT) talks to Dr. Laura Marandino (GB) about "The first-line treatment strategies for metastatic renal cell carcinoma...
2 Maalis 202414min
ASCO GU24 special: Prof. Christophe Hennequin on GETUG-AFU 18 trial results
UROONCO PCa associate editor Dr. Constance Thibault (FR) talks to Prof. Christophe Hennequin from Saint-Louis Hospital, France about the GETUG-AFU 18 trial results he presented at ASCO GU24 in San Fra...
25 Helmi 20243min
Special series on RCC: Role of cytoreductive nephrectomy for mRCC with Assist. Prof. Mari and Prof. Badani
In 'Episode 1' of a series on "Metastatic renal cell carcinoma", Assist. Prof. Andrea Mari (IT) and Prof. Ketan Badani (US) discuss "The role of cytoreductive nephrectomy for metastatic renal cell car...
18 Helmi 202414min
ASCO GU24 special: Prof. Michael Hofman talks about a novel CA IX-targeting peptide
In this podcast, UROONCO RCC chief editor Dr. Carmen Mir (ES) interviews Prof. Michael Hofman from the Peter MacCallum Cancer Centre, Australia, on the results of his study “First-in-human safety, ima...
14 Helmi 20246min
ASCO GU24 special: Prof. Nizar Tannir shares CheckMate 214 results
In this podcast, UROONCO RCC chief editor Dr. Carmen Mir interviews Prof. Nizar Tannir from the University of Texas, MD Anderson Cancer Center, USA, on the long-term follow-up data from the phase 3 Ch...
11 Helmi 202413min
ASCO GU24 special: Dr. Kim Chi discusses CONTACT-2 results
In this podcast interview live from ASCO GU24 in San Francisco, UROONCO PCa associate editor Dr. Constance Thibault (FR) talks to medical oncologist Dr. Kim Chi from the University of British Columbia...
7 Helmi 20244min
ASCO GU24 special: Assoc. Prof. Barata discusses the results of KEYNOTE-564 and CheckMate-914
In this podcast, UROONCO RCC chief editor Dr. Carmen Mir (ES) interviews Assoc. Prof. Pedro Barata from University Hospitals Seidman Cancer Center, USA, about the results of two adjuvant RCC studies: ...
4 Helmi 202410min
